VMP 42271511000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Fluoxetine 10mg capsules
BNF code 0403030E0AAALAL
Virtual Therapeutic Moiety Fluoxetine
Date identifier became valid 22 Sep 2023
Previous product identifier 373959000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units capsule
Unit dose unit of measure capsule
Virtual Product Ingredient
Ingredient Fluoxetine hydrochloride
Basis of pharmaceutical strength Based on Base Substance
Basis of strength substance identifier 372767007
Strength value numerator 10.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route capsule.oral
Dose Form
Formulation Oral capsule
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Fluoxetine 10mg capsules (A A H Pharmaceuticals Ltd)
Fluoxetine 10mg capsules (Accord-UK Ltd)
Fluoxetine 10mg capsules (Alliance Healthcare (Distribution) Ltd)
Fluoxetine 10mg capsules (Genesis Pharmaceuticals Ltd)
Fluoxetine 10mg capsules (Key Pharmaceuticals Ltd)
Fluoxetine 10mg capsules (Medihealth (Northern) Ltd)
Fluoxetine 10mg capsules (Medreich Plc)
Fluoxetine 10mg capsules (Morningside Healthcare Ltd)
Fluoxetine 10mg capsules (Teva UK Ltd)
Virtual Medicinal Product Packs
Fluoxetine 10mg capsules 30 capsule

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback